AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Conference co-chair Lee J. Helman of the National Cancer Institute in Bethesda, Maryland, discusses the features and anticipated highlights of this conference ...
American Association for Cancer Research
Trachette Jackson: Mathematical modeling of targeted cancer therapeutics
Increased understanding of the molecular drivers of tumor initiation and progression has led to targeted manipulation of intracellular signaling pathways for ...
Centre International de Rencontres Mathématiques
Nuclear Medicine: A Potential Game Changer for Advanced Prostate Cancer
Please note that recruitment of patients for the clinical trial will start in late 2017. If you are interested in participating you should discuss with your medical ...
Prostate Cancer Foundation of Australia
Cancer Metabolism: From molecules to medicine
It takes years to discover and develop a new medication. But what does this long-term, complicated process actually involve? In this seminar, Harvard Medical ...
Harvard Medical School
BCI Cancer Therapeutics and Molecular Pathology & Genomics MSc courses
Do you want to study the theory and practices of cancer therapy or the molecular biology of cancer at a world-class medical school? Our MSc courses might be ...
BCIQMUL
Targeting Cancer Pathways: The Tumor Microenvironment
Rakesh K. Jain, PhD (Harvard Medical School/MGH), and Padmanee Sharma, MD, PhD (MD Anderson Cancer Center) ⬇️ Expand “Show More” to view ...
Cell Signaling Technology, Inc.
Camera on Cancer Research: Unraveling the Molecular Mechanisms of Neuroblastoma
Dr. Carol Thiele, Head of the Cell and Molecular Biology Section in the Pediatric Oncology Branch, takes you into her lab where she researches the molecular ...
National Cancer Institute
microRNAs in breast cancer – Video Abstract [ID 43799]
Video abstract of a review paper “Critical analysis of the potential for microRNA biomarkers in breast cancer management” published in the open access Breast ...
Dove Medical Press
Can we cure genetic diseases by rewriting DNA? | David R. Liu
In a story of scientific discovery, chemical biologist David R. Liu shares a breakthrough: his lab's development of base editors that can rewrite DNA. This crucial ...
TED
Molecular Profiling Improved Cancer Therapy
The median survival rate for cancer patients who received targeted matched therapy improved by 4.4 months, a new study showed. Dr. Apostolia-Maria ...
MDedge: news and insights for busy physicians
4D Molecular Therapeutics
Elizabeth Alcamo, Ph.D., Senior Director, Corporate Development Emeryville, CA (Private) 4D Molecular Therapeutics (4DMT) is focused on the discovery and ...
Alliance for Regenerative Medicine
Adjuvant/Neoadjuvant Therapy for Breast Cancer: Updates and Molecular Predictors of Benefit
In this presentation from the 14th Annual Best of San Antonio - Breast Cancer: Bench to Bedside, Dr. Kathy S. Albain discusses updates in adjuvant and ...
ImedexCME
Comprehensive Molecular Profiling to Support Treatment Recommendations for Advanced Cancer
Comprehensive Molecular Profiling to Support Treatment Recommendations for Advanced Cancer Air date: Wednesday, November 13, 2013, 3:00:00 PM ...
NIH VideoCast
Harnessing Cross Talk Between Signaling Pathways to Improve Cancer Tr
Michael B. Yaffe, Ph.D., M.D., Professor of Biology and Biological Engineering at MIT, discussed his work examining the use of multiple anti-cancer therapeutics ...
Cell Signaling Technology, Inc.
A “key” discovery: Targeting DNA knots for cancer therapeutics | Caitlin Miron | TEDxQueensU
At least 85% of cancer cells take advantage of cellular processes controlled by unusual DNA “knots” known as guanine quadruplexes. Caitlin Miron, PhD ...
TEDx Talks
Interrogating Circulating Tumor Cells to Direct Targeted Cancer Therapies
Air date: Wednesday, May 26, 2010, 3:00:00 PM Time displayed is Eastern Time, Washington DC Local Category: Wednesday Afternoon Lectures Description: ...
NIH VideoCast
Noninvasive Techniques in Brain Tumor Treatment
Noninvasive techniques are an important part of cancer therapy. Methods such as identifying biomarkers and molecular imaging are useful for indicating ...
MassGeneralHospital
New Therapies for Brain Tumors
Brain tumors are difficult to treat because the brain has natural barriers that can resist therapy. In this video, Bakhos A. Tannous, PhD, director of the ...
MassGeneralHospital
Targeted Therapeutics at City of Hope: Attacking Disease on the Molecular Level
By investigating the mechanisms that activate or inhibit respective genes, researchers are developing designer drugs to target specific disease-causing ...
City of Hope
SABCS 2013: Triple-Negative Therapy and Chemotherapy
Drs. Eric Winer, Stephen Sener, William Gradishar, and Joyce O'Shaugnessey comprise the faculty for this compelling group of Best of the Day interviews with ...
ImedexCME
Pathology Insights: Diagnosing Lung Cancer on Small Specimens with Jordan Reynolds, MD
Dr. Jordan Reynolds, anatomic and molecular pathologist, discusses a case that illustrates how to diagnose lung cancer on small specimens.
Cleveland Clinic
Hormone Receptor-Positive and HER2-Positive Breast Cancer: A Medical Update
Featuring Sara Hurvitz, MD, FACP, learn about the use of targeted therapies for early-stage, hormone receptor-positive and HER2-positive breast cancer, ...
Living Beyond Breast Cancer
Novel Therapeutics for Breast Cancer: HER2+ and Triple Negative Disease; New Pathways, Targets
In this presentation from the 14th Annual Best of San Antonio - Breast Cancer: Bench to Bedside, Dr. Debu Tripathy discusses novel therapeutics for the ...
ImedexCME
Dr. Pegram on Developing Agents for Patients With HER2+ Breast Cancer and Brain Metastases
Mark D. Pegram, MD, Susy Yuan-Huey Hung Professor, co-director, Stanford's Molecular Therapeutics Program, director, Breast Cancer Oncology Program, ...
OncLiveTV
Dr Marina Pajic - Pancreatic Cancer Genome Sequencing
Garvan's Dr Marina Pajic (http://www.garvan.org.au/research/cancer/pancreatic-cancer-research/personalised-cancer-therapeutics/marpaj) presenting "Cancer ...
Garvan Institute of Medical Research
Informatics - "Introduction to Molecular Pathology" - Aaron Bossler, MD
University of Iowa Health Care
Dr. William Oh on Prostate Cancer Monitoring
William K. Oh, M.D. is the Chief of the Division of Hematology and Medical Oncology; Professor of Medicine and Urology; and Ezra M. Greenspan, MD Professor ...
Mount Sinai Health System
Advances in AMPK and Autophagy Signaling
The webinar touches upon the following key points: - AMPK is a master regulator of organismal metabolism - Identification and characterization of novel AMPK ...
Cell Signaling Technology, Inc.
Benefits of targeted therapeutics in Lung Cancer
David Carbone, MD, PhD from Ohio State University, Columbus, OH discusses the benefits of using targeted therapeutics in the treatment of lung cancer.
VJOncology
IGHV and TP53 Sequencing: Clinical Utility in Chronic Lymphocytic Leukemia (CLL)
In this month's “Hot Topic,” Dr. Curt Hanson will discuss the use of laboratory-based prognostic markers in patients with chronic lymphocytic leukemia (CLL).
Mayo Clinic Laboratories
TRACO 2018 - Non-small cell lung cancer and Genomics
Air date: Monday, November 5, 2018, 4:00:00 PM Time displayed is Eastern Time, Washington DC Local Views: Total views: 40, (21 Live, 19 On-demand) ...
NIH VideoCast
Janet Rowley's Vision: Treating Cancer at the Molecular Level
Janet Rowley, MD, sparked a revolution in cancer genetics and continues to shape the field of personalized medicine today. Rowley and her fellow University of ...
UChicago Medicine
Dr. Ranee Mehra on Molecular Testing in NSCLC
Commentary from Ranee Mehra, MD, Attending Physician, Fox Chase Cancer Center, about molecular testing in non-small cell lung cancer (NSCLC)
Novartis
San Antonio Breast Cancer Symposium
SABCS is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and ...
American Association for Cancer Research
Ali Shilatifard’s Lab: Studying Epigenetic Basis of Cancer
Ali Shilatifard, PhD, has dedicated his career to revealing the causes of childhood leukemia and other cancers and providing detailed molecular insight into the ...
NUFeinbergMed
Personalized Medicine and the Future of Pathology at Penn
The Department of Pathology and Laboratory Medicine, in conjunction with the Abramson Cancer Center, is at the leading edge of personalized medicine with ...
Penn Medicine
New Mechanistic Insights into Inflammation Triggered by Invasive Infection
Sounding the Alarm and Putting Out the Fire: New Mechanistic Insights into Inflammation Triggered by Invasive Infection Air date: Wednesday, May 30, 2018, ...
NIH VideoCast
Cancer Research Institute Postdoctoral Fellow Diego Acosta-Alvear on Multiple Myeloma Research
Cancer Research Institute postdoctoral fellow Diego Acosta-Alvear, Ph.D., in the laboratory of Peter Walter, Ph.D., at the University of California, San Francisco ...
Cancer Research Institute
Adjuvant Therapy for High-Risk HER2+ Breast Cancer
Hope S. Rugo, MD, provides preliminary insight on patient selection for pertuzumab or neratinib in the adjuvant setting and highlights the importance of ...
OncLiveTV
Tumor microenvironment – TIL isolation and flow cytometry analysis [WEBINAR]
Best practices for isolation of tumor infiltrating leukocytes (TILs) and present an optimized workflow for faster and improved flow analysis ...
Miltenyi Biotec
Keynote Lecture: The Microbiome in GI Cancer - How Relevant is it?
Earn CME for related activities: https://www.naccme.com/oln In this webcast from the '2019 ESMO World Congress on Gastrointestinal Cancer', Dr. Jeroen Raes ...
ImedexCME
SWI/SNF Mutations in Cancer - Diana Hargreaves, Salk Institute
SWI/SNF Mutations in Cancer Diana Hargreaves, Ph.D., Assistant Professor, Molecular and Cell Biology Laboratory, Salk Institute for Biological Studies.
Alliance for Regenerative Medicine
